{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:37:34Z","timestamp":1771101454392,"version":"3.50.1"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fragile X syndrome (FXS) is the first of 3 syndromes identified as a health condition related to fragile X mental retardation (FMR1) gene dysfunction. The other 2 syndromes are fragile X\u2013associated primary ovarian insufficiency syndrome (FXPOI) and fragile X\u2013associated tremor\/ataxia syndrome (FXTAS), which together are referred to as fragile X\u2013associated disorders (FXDs). Collectively, this group comprises the 3 faces of fragile X. Even though the 3 conditions share a common genetic defect, each one is a separate health condition that results in a variety of body function impairments such as motor delay, musculoskeletal issues related to low muscle tone, coordination limitations, ataxia, tremor, undefined muscle aches and pains, and, for FXTAS, a late-onset neurodegeneration. Although each FXD condition may benefit from physical therapy intervention, available evidence as to the efficacy of intervention appropriate to FXDs is lacking. This perspective article will discuss the genetic basis of FMR1 gene dysfunction and describe health conditions related to this mutation, which have a range of expressions within a family. Physical therapy concerns and possible assessment and intervention strategies will be introduced. Understanding the intergenerational effect of the FMR1 mutation with potential life-span expression is a key component to identifying and treating the health conditions related to this specific genetic condition.<\/jats:p>","DOI":"10.2522\/ptj.20140430","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T01:59:25Z","timestamp":1466733565000},"page":"1782-1790","source":"Crossref","is-referenced-by-count":12,"title":["Three Faces of Fragile X"],"prefix":"10.1093","volume":"96","author":[{"given":"Cornelia C.E.","family":"Lieb-Lundell","sequence":"first","affiliation":[{"name":"C.C.E. Lieb-Lundell, PT, DPT, Physical Therapy Program, University of St Augustine for Health Sciences, San Marcos, CA 92069 (USA)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2020010206494881600_B1","volume-title":"Understanding Fragile X Syndrome","author":"Carvajal","year":"2011"},{"key":"2020010206494881600_B2","unstructured":"National Fragile X Foundation. Fragile X-associated disorders. Updated 2016. Available at: https:\/\/fragilex.org\/fragile-x\/. Accessed March 10, 2016."},{"key":"2020010206494881600_B3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2009.02.007","article-title":"FMR1: a gene with three faces","volume":"1790","author":"Oostra","year":"2009","journal-title":"Biochem Biophys Acta"},{"key":"2020010206494881600_B4","unstructured":"Saul, RA, Tarleton, J. FMR1-related disorders. GeneReviews. Initial posting: June 16, 1998; last revision: April 26, 2012. Available at: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1384\/. Accessed January 15, 2016."},{"key":"2020010206494881600_B5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2217\/fnl.09.44","article-title":"Evidence for RNA-mediated toxicity in the fragile X-associated tremor\/ataxia syndrome","volume":"4","author":"Galloway","year":"2009","journal-title":"Future Neurol"},{"issue":"3","key":"2020010206494881600_B6","first-page":"18","article-title":"Rooting out genetic links","volume":"1","author":"Ries","year":"2009","journal-title":"PT in Motion"},{"key":"2020010206494881600_B7","volume-title":"Guide to Physical Therapist Practice 3.0","year":"2014"},{"key":"2020010206494881600_B8","unstructured":"American Physical Therapy Association. Genetics literacy for physical therapists. HOD P06\u201301-28-27 [Position]. Available at: http:\/\/www.apta.org\/uploadedFiles\/APTAorg\/About_Us\/Policies\/Health_Social_Environment\/GeneticsLiteracyPTs.pdf. Accessed March 20, 2016."},{"key":"2020010206494881600_B9","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-5805-1","volume-title":"The Fragile X-Associated Tremor\/Ataxia Syndrome (FXTAS)","author":"Tassone","year":"2010"},{"key":"2020010206494881600_B10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/hmg\/9.6.901","article-title":"Understanding the molecular basis of fragile X syndrome","volume":"9","author":"Peng","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2020010206494881600_B11","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21493","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines","volume":"22","author":"Berry-Kravis","year":"2007","journal-title":"Mov Disord"},{"key":"2020010206494881600_B12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.GIM.0000182468.22666.dd","article-title":"Fragile X syndrome: diagnostic and carrier testing","volume":"7","author":"Sherman","year":"2005","journal-title":"Genet Med"},{"key":"2020010206494881600_B13","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/ajmg.a.33054","article-title":"Conversion disorder in women with the FMR1 premutation","volume":"149A","author":"Seritan","year":"2009","journal-title":"Am J Med Genet A"},{"key":"2020010206494881600_B14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-62703-411-1_1","article-title":"A brief history of triplets repeat diseases","volume":"1010","author":"Budworth","year":"2013","journal-title":"Methods Mol Biol"},{"key":"2020010206494881600_B15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrg2748","article-title":"Repeat expansion disease: progress and puzzles in disease pathogenesis","volume":"11","author":"La Spada","year":"2010","journal-title":"Nat Rev Genet"},{"key":"2020010206494881600_B16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/scan\/nsl028","article-title":"Autism: lesson from the X chromosome","volume":"1","author":"Marco","year":"2006","journal-title":"Soc Cogn Affect Neurosci"},{"key":"2020010206494881600_B17","first-page":"23","article-title":"X inactivation plays a major role in the gender bias in somatic expansion in a mouse model of the fragile X-related disorders: implications for the mechanism of repeat expansion","volume":"15","author":"Adihe","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2020010206494881600_B18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1474-4422(06)70676-7","article-title":"Fragile-X syndrome and fragile-X-associated tremor\/ataxia syndrome: two faces of FMR1","volume":"6","author":"Jacquemont","year":"2007","journal-title":"Lancet Neurol"},{"key":"2020010206494881600_B19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.parkreldis.2014.01.006","article-title":"Parkinsonism in fragile X-associated tremor\/ataxia syndrome (FXTAS): revisited","volume":"20","author":"Niu","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"2020010206494881600_B20","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/brain\/awf184","article-title":"Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers","volume":"125","author":"Greco","year":"2002","journal-title":"Brain"},{"key":"2020010206494881600_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-5805-1_1","article-title":"Clinical neurological phenotype of FXTAS","volume-title":"The Fragile X-Associated Tremor\/Ataxia Syndrome (FXTAS)","author":"Leehey","year":"2010"},{"key":"2020010206494881600_B22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ajmg.a.32060","article-title":"Expanded clinical phenotype of women with the FMR1 premutation","volume":"146A","author":"Coffey","year":"2008","journal-title":"Am J Med Genetics A"},{"key":"2020010206494881600_B23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.1320380221","article-title":"Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features","volume":"38","author":"Cronister","year":"1991","journal-title":"Am J Med Genet"},{"key":"2020010206494881600_B24","unstructured":"Aubertine, G ; Consensus of the Fragile X Clinical & Research Consortium on Clinical Practices. Fragile X-Associated Primary Ovarian Insufficiency (FXPOI). First issued: June 2011. Updated: October 2012. Available at: https:\/\/fragilex.org\/wp-content\/uploads\/2012\/08\/Fragile-X-associated-Primary-Ovarian-Insufficiency2012-Oct.pdf. Accessed March 10, 2016."},{"key":"2020010206494881600_B25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/AOG.0b013e318163be0b","article-title":"Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis","volume":"111","author":"Cronister","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2020010206494881600_B26","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1093\/hmg\/ddq166","article-title":"Advances in understanding the molecular basis of FXTAS","volume":"19","author":"Garcia-Arocena","year":"2010","journal-title":"Human Mol Genet"},{"key":"2020010206494881600_B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-1-12","article-title":"Fragile X and autism: intertwined at the molecular level leading to targeted treatments","volume":"1","author":"Hagerman","year":"2010","journal-title":"Mol Autism"},{"key":"2020010206494881600_B28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome","volume":"123","author":"Hagerman","year":"2009","journal-title":"Pediatrics"},{"key":"2020010206494881600_B29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1469-8749.1992.tb11521.x","article-title":"The fragile X syndrome","volume":"34","author":"Goldson","year":"1992","journal-title":"Dev Med Child Neurol"},{"key":"2020010206494881600_B30","unstructured":"Budimirovic, D, Haas-Givler, B, Blitz, R, ; Consensus of the Fragile X Clinical & Research Consortium on Clinical Practices. Autism spectrum disorders in fragile x syndrome. 2014. Available at: https:\/\/fragilex.org\/wp-content\/uploads\/2012\/08\/Autism-Spectrum-Disorder-in-Fragile-X-Syndrome-2014-Nov.pdf. Accessed April 10, 2016."},{"key":"2020010206494881600_B31","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013","edition":"5th ed"},{"key":"2020010206494881600_B32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1352\/2008.113:427-438","article-title":"Autism profiles of males with fragile X syndrome","volume":"113","author":"Hagerman","year":"2008","journal-title":"Am J Ment Retard"},{"key":"2020010206494881600_B33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1023\/A:1026000404855","article-title":"Autism: the point of view from fragile X studies","volume":"28","author":"Feinstein","year":"1998","journal-title":"J Autism Dev Disord"},{"key":"2020010206494881600_B34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1399-0004.2011.01723.x","article-title":"CGG repeat in the FMR1 gene: size matters","volume":"80","author":"Willemensen","year":"2011","journal-title":"Clin Genet"},{"key":"2020010206494881600_B35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/302774","article-title":"Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations","volume":"66","author":"Hundscheid","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2020010206494881600_B36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4088\/JCP.09m05407blu","article-title":"Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers","volume":"72","author":"Burgeois","year":"2011","journal-title":"J Clin Psychiartry"},{"key":"2020010206494881600_B37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1866-1955-6-30","article-title":"Associated features in females with an FMR1 mutation","volume":"6","author":"Wheeler","year":"2014","journal-title":"J Neurodev Disord"},{"key":"2020010206494881600_B38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"key":"2020010206494881600_B39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2310\/JIM.0b013e3181af59c4","article-title":"Fragile X-associated tremor\/ataxia syndrome (FXTAS): clinical phenotype, diagnosis and treatment","volume":"57","author":"Leehey","year":"2009","journal-title":"J Investig Med"},{"key":"2020010206494881600_B40","unstructured":"Berman, R, Schwartzer, JJ, Hunsaker, MR. Mouse models of the fragile X-associated tremor\/ataxia syndrome (FXTAS) and the fragile X premutation. In: Movement Disorders Genetics and Models. 2nd ed. Available at: http:\/\/mrhunsaker.github.io\/CGGKIMotor\/. Accessed March 1, 2016."},{"key":"2020010206494881600_B41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/BJ20091960","article-title":"Evidence of mitochondrial dysfunction in fragile X-associated tremor\/ataxia syndrome","volume":"429","author":"Ross-Inta","year":"2010","journal-title":"Biochem J"},{"key":"2020010206494881600_B42","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2522\/ptj.2010.mcmillan.lecture","article-title":"41st Mary McMillan Lecture: Destiny is now","volume":"90","author":"Guccione","year":"2010","journal-title":"Phys Ther"},{"key":"2020010206494881600_B43","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2522\/ptj.20070346","article-title":"Physical therapy intervention for people with Huntington disease","volume":"88","author":"Busse","year":"2008","journal-title":"Phys Ther"},{"key":"2020010206494881600_B44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0888439002250448","article-title":"Effectiveness of physiotherapy, occupational therapy, and speech pathology for people with Huntington's disease: a systematic review","volume":"17","author":"Bilney","year":"2003","journal-title":"Neurorehabil Neural Repair"},{"key":"2020010206494881600_B45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","article-title":"Physical therapy management of Pompe disease","volume":"8","author":"Case","year":"2006","journal-title":"Genet Med"},{"key":"2020010206494881600_B46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/NPT.0b013e3181990fcc","article-title":"The effects of exercise on balance in persons with Parkinson's disease: a systematic review across the disability spectrum","volume":"33","author":"Dibble","year":"2009","journal-title":"J Neurol Phys Ther"},{"key":"2020010206494881600_B47","first-page":"CD002815","article-title":"Physiotherapy for Parkinson's disease: a comparison of techniques","volume":"6","author":"Tomlinson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020010206494881600_B48","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/mds.23222","article-title":"Long-term effects of coordinative training in degenerative cerebellar disease","volume":"25","author":"Ilg","year":"2010","journal-title":"Mov Disord"},{"key":"2020010206494881600_B49","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2522\/ptj.20060232","article-title":"Presentation and progression of Friedreich ataxia and implications for physical therapist examination","volume":"78","author":"Maring","year":"2007","journal-title":"Phys Ther"},{"key":"2020010206494881600_B50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0269215508097853","article-title":"Effectiveness of physiotherapy for adults with cerebellar dysfunction: a systematic review","volume":"23","author":"Martin","year":"2009","journal-title":"Clin Rehab"},{"key":"2020010206494881600_B51","unstructured":"Hall, DA, O'Keefe, JA. Fragile X-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment. Tremor Other Hyperkinet Mov (NY). 2012;2. pii: tre-02-56-352-1. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3570061\/. Accessed March 5, 2016."},{"key":"2020010206494881600_B52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.rehab.2014.01.002","article-title":"The assessment and treatment of postural disorder in cerebellar ataxia: a systematic review","volume":"57","author":"Marquer","year":"2014","journal-title":"Ann Phys Rehabil Med"},{"key":"2020010206494881600_B53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1866-1955-6-31","article-title":"Emerging topics in FXTAS","volume":"6","author":"Hall","year":"2014","journal-title":"J Neurodev Disord"},{"key":"2020010206494881600_B54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1542\/peds.2010-3500","article-title":"Health supervision for children with fragile X syndrome","volume":"127","author":"Hersh","year":"2011","journal-title":"Pediatrics"},{"key":"2020010206494881600_B55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00001163-200610000-00003","article-title":"Activity-focused motor interventions for infants and young children with neurological conditions","volume":"19","author":"Valvano","year":"2006","journal-title":"Infants Young Child"},{"key":"2020010206494881600_B56","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.apmr.2007.10.023","article-title":"The interaction between executive attention and postural control in dual task conditions: children with cerebral palsy","volume":"89","author":"Reilly","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"2020010206494881600_B57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/ptj\/77.6.629","article-title":"Evaluation of postural stability in children: current theories and assessment tools","volume":"77","author":"Wescott","year":"1997","journal-title":"Phys Ther"},{"key":"2020010206494881600_B58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/PEP.0000000000000011","article-title":"Efficacy of orthosis for children with hypotonia: a systematic review","volume":"26","author":"Weber","year":"2014","journal-title":"Peds Phys Ther"},{"key":"2020010206494881600_B59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/hrt.61.3.289","article-title":"Cardiac abnormalities in the fragile X syndrome","volume":"61","author":"Sreeram","year":"1989","journal-title":"Br Heart J"},{"key":"2020010206494881600_B60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v67n0112","article-title":"Psychiatric phenotype of the fragile X-associated tremor\/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia","volume":"67","author":"Bacalman","year":"2006","journal-title":"J Clin Psychiat"},{"key":"2020010206494881600_B61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5582\/irdr.2014.01029","article-title":"Current research, diagnosis, and treatment of fragile X-associated tremor\/ataxia syndrome","volume":"3","author":"Muzar","year":"2014","journal-title":"Intractable Rare Dis Res"},{"key":"2020010206494881600_B62","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMsb042979","article-title":"The family history: more important than ever","volume":"351","author":"Gultmacher","year":"2004","journal-title":"N Engl J Med"},{"key":"2020010206494881600_B63","unstructured":"US Department of Health & Human Services. The Surgeon General's family health history initiative. Available at: http:\/\/www.hhs.gov\/familyhistory. Accessed January 1, 2016."},{"key":"2020010206494881600_B64","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1542\/peds.2007-0820","article-title":"State-of-the-art review article: ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues","volume":"121","author":"Bailey","year":"2008","journal-title":"Pediatrics"},{"key":"2020010206494881600_B65","first-page":"e1","article-title":"Prenatal screening for fragile X: carriers, controversies, and counseling","volume":"6","author":"Guti\u00e9rrez","year":"2013","journal-title":"Rev Obstet Gynecol"},{"key":"2020010206494881600_B66","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1542\/peds.111.2.407","article-title":"Discovering fragile X syndrome; family experiences and perceptions","volume":"111","author":"Bailey","year":"2003","journal-title":"Pediatrics"},{"key":"2020010206494881600_B67","first-page":"CD001806","article-title":"Preconception and antenatal screening for the fragile site on the X-chromosome","volume":"1","author":"Kornman","year":"2003","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Physical Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ptj\/article-pdf\/96\/11\/1782\/31675536\/ptj1782.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ptj\/article-pdf\/96\/11\/1782\/31675536\/ptj1782.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T21:25:20Z","timestamp":1718659520000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ptj\/article\/96\/11\/1782\/2870040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.2522\/ptj.20140430","relation":{},"ISSN":["0031-9023","1538-6724"],"issn-type":[{"value":"0031-9023","type":"print"},{"value":"1538-6724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}